BioLineRx Ltd. (BLRX) Financials
BLRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 52.9 million | 39.7 million |
2023-06-30 | 58.9 million | 37.9 million |
2023-03-31 | 68.6 million | 29.5 million |
2022-12-31 | 76.4 million | 25.5 million |
BLRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -9.9 million | 472000 |
2023-06-30 | -9.8 million | 485000 |
2023-03-31 | -8.1 million | 435000 |
2022-12-31 | -5.9 million | 1.0 million |
BLRX Net Income
No data available :(
BLRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 26.0 million | - | 1.8 million |
2023-06-30 | 32.8 million | - | 2.0 million |
2023-03-31 | 43.3 million | - | 2.1 million |
2022-12-31 | 51.1 million | - | 2.2 million |
BLRX Shares Outstanding
BLRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 27000 | 2.7 million | 1.5 million | 8.1 million |
2023-06-30 | 123000 | 3.0 million | 1.3 million | 5.6 million |
2023-03-31 | 129000 | 3.7 million | 1.3 million | 3.9 million |
2022-12-31 | 228000 | 3.4 million | 1.6 million | 3.4 million |
BLRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 221000 |
2023-06-30 | - | 198000 |
2023-03-31 | - | - |
2022-12-31 | - | 187000 |
BLRX
Price: $0.68
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.75 USD
P/E Ratio: -1.52
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 60.9 million